Mode of Childbirth and Long-term Outcomes in Women With Inflammatory Bowel Diseases

Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A. Farraye, MD, MSc, FACG Jonathan A. Leighton MD, FACG Oral 58: Mode of Childbirth and Long-term Outcomes in Women With Inflammatory ...

Health Outcomes of Ulcerative Colitis (UC) and Crohn’s Disease (CD) Patients Hospitalized With Human Cytomegalovirus (CMV) Disease

Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A. Farraye, MD, MSc, FACG Jonathan A. Leighton MD, FACG Oral 62: Health Outcomes of Ulcerative Colitis (UC) and Crohn’s ...

Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids: A Systematic Review and Meta-Analysis

Plenary Session 2: IBD Monday, October 20 2:15 pm – 3:00 pm MODERATORS:     Uma Mahadevan, MD, FACG Sunanda V. Kane, MD, MSPH, FACG Oral 15: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory ...

The Risk of a Second Non-Melanoma Skin Cancer With Thiopurine and Anti-TNF Use in Inflammatory Bowel Disease

Plenary Session 1: IBD / Small Intestine / Unclassified Wednesday, October 22 8:30 am – 10:15 am Moderators: Francis A. Farraye, MD, MSc, FACG Jonathan A. Leighton MD, FACG Oral 63: The Risk of a Second Non-Melanoma Skin Cancer With Thiopurine ...

Colonoscopy Is Associated With a Reduced Risk of Colon Cancer and Mortality in Patients With Inflammatory Bowel Diseases

PRESIDENT’S PLENARY SESSION 2 Monday October 20 9:30 am – 10:30 am (Terrace Ballroom) Moderators:      Stephen B. Hanauer, MD, FACG John R. Saltzman, MD, FACG Oral 9: Colonoscopy Is Associated With a Reduced Risk of Colon Cancer ...

Safety of Vedolizumab Alone or With Concomitant Corticosteroids and/or Immunosuppressants in Patients With Ulcerative Colitis or Crohn’s Disease

Plenary Session 2: IBD Monday, October 20 2:15 pm – 3:00 pm MODERATORS:    Uma Mahadevan, MD, FACG Sunanda V. Kane, MD, MSPH, FACG Oral 16: Safety of Vedolizumab Alone or With Concomitant Corticosteroids and/or Immunosuppressants in Patients ...